Cargando…
Impairment of the autophagy–lysosomal pathway in Alzheimer's diseases: Pathogenic mechanisms and therapeutic potential
Alzheimer's disease (AD), the most common neurodegenerative disorder, is characterized by memory loss and cognitive dysfunction. The accumulation of misfolded protein aggregates including amyloid beta (Aβ) peptides and microtubule associated protein tau (MAPT/tau) in neuronal cells are hallmark...
Autores principales: | Zhang, Wei, Xu, Chengchao, Sun, Jichao, Shen, Han-Ming, Wang, Jigang, Yang, Chuanbin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9069408/ https://www.ncbi.nlm.nih.gov/pubmed/35530153 http://dx.doi.org/10.1016/j.apsb.2022.01.008 |
Ejemplares similares
-
The role of melatonin in the treatment of type 2 diabetes mellitus and Alzheimer's disease
por: Shen, Shengnan, et al.
Publicado: (2022) -
Curcumin targets the TFEB-lysosome pathway for induction of autophagy
por: Zhang, Jianbin, et al.
Publicado: (2016) -
Autophagy-Lysosomal Pathway as Potential Therapeutic Target in Parkinson’s Disease
por: Bonam, Srinivasa Reddy, et al.
Publicado: (2021) -
A novel autophagy activator ginsenoside Rh2 enhances the efficacy of immunogenic chemotherapy
por: Yang, Jing, et al.
Publicado: (2023) -
Novel Insight into Functions of Transcription Factor EB (TFEB) in Alzheimer’s Disease and Parkinson’s Disease
por: Yang, Jing, et al.
Publicado: (2023)